|

IC Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 3: 1

Top Sponsors

  • Genmab1

Indications

  • Recurrent or Progressive Endometrial Cancer1
  • Endometrial Cancer1
  • Cancer1

Washington D.C., District of Columbia1 trial

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

MedStar Washington Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.